Literature DB >> 17675372

Tryptophan hydroxylase 1 knockout and tryptophan hydroxylase 2 polymorphism: effects on hypoxic pulmonary hypertension in mice.

M Izikki1, N Hanoun, E Marcos, L Savale, A M Barlier-Mur, F Saurini, S Eddahibi, M Hamon, S Adnot.   

Abstract

Serotonin [5-hydroxytryptamine (5-HT)] biosynthesis depends on two rate-limiting tryptophan hydroxylases (Tph): Tph1, which is expressed in peripheral organs, and Tph2, which is expressed in neurons. Because 5-HT is involved in pulmonary hypertension (PH), we investigated whether genetic variations in Tph1 and/or Tph2 affected PH development in mice. To examine the functional impact of peripheral Tph1 deficiency on hypoxic PH, we used Tph1(-/-) mice characterized by very low 5-HT synthesis rates and contents in the gut and lung and increased 5-HT synthesis in the forebrain. With chronic hypoxia, 5-HT synthesis in the forebrain increased further. Hypoxic PH, right ventricular hypertrophy, and distal pulmonary artery muscularization were less severe (P < 0.001) than in wild-type controls. The Tph inhibitor p-chlorophenylalanine (100 mgxkg(-1)xday(-1)) further improved these parameters. We then investigated whether mouse strains harboring the C1473G polymorphism of the Tph2 gene showed different PH phenotypes during hypoxia. Forebrain Tph activity was greater and hypoxic PH was more severe in C57Bl/6 and 129X1/SvJ mice homozygous for the 1473C allele than in DBA/2 and BALB/cJ mice homozygous for the 1473G allele. p-Chlorophenylalanine reduced PH in all groups and abolished the difference in PH severity across mouse strains. Hypoxia increased 5-hydroxytryptophan accumulation but decreased 5-HT contents in the forebrain and lung, suggesting accelerated 5-HT turnover during hypoxia. These results provide evidence that dysregulation of 5-HT synthesis is closely linked to the hypoxic PH phenotype in mice and that Tph1 and Tph2 may contribute to PH development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17675372     DOI: 10.1152/ajplung.00082.2007

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  21 in total

1.  Paracrine modulation of cholangiocyte serotonin synthesis orchestrates biliary remodeling in adults.

Authors:  Alessia Omenetti; Liu Yang; Raul R Gainetdinov; Cynthia D Guy; Steve S Choi; Wei Chen; Marc G Caron; Anna Mae Diehl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-11-11       Impact factor: 4.052

2.  Mice deficient in Mkp-1 develop more severe pulmonary hypertension and greater lung protein levels of arginase in response to chronic hypoxia.

Authors:  Yi Jin; Thomas J Calvert; Bernadette Chen; Louis G Chicoine; Mandar Joshi; John Anthony Bauer; Yusen Liu; Leif D Nelin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-02-19       Impact factor: 4.733

3.  On the presence of serotonin in mammalian cardiomyocytes.

Authors:  Klaus Pönicke; Ulrich Gergs; Igor B Buchwalow; Steffen Hauptmann; Joachim Neumann
Journal:  Mol Cell Biochem       Date:  2012-02-25       Impact factor: 3.396

Review 4.  Advances in tryptophan hydroxylase-2 gene expression regulation: new insights into serotonin-stress interaction and clinical implications.

Authors:  Guo-Lin Chen; Gregory M Miller
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-03       Impact factor: 3.568

5.  Elevated transglutaminase 2 activity is associated with hypoxia-induced experimental pulmonary hypertension in mice.

Authors:  Thomas R DiRaimondo; Cornelius Klöck; Rod Warburton; Zachary Herrera; Krishna Penumatsa; Deniz Toksoz; Nicholas Hill; Chaitan Khosla; Barry Fanburg
Journal:  ACS Chem Biol       Date:  2013-11-05       Impact factor: 5.100

6.  Gene therapy by targeted adenovirus-mediated knockdown of pulmonary endothelial Tph1 attenuates hypoxia-induced pulmonary hypertension.

Authors:  Ian Morecroft; Katie White; Paola Caruso; Margaret Nilsen; Lynn Loughlin; Raul Alba; Paul N Reynolds; Sergei M Danilov; Andrew H Baker; Margaret R Maclean
Journal:  Mol Ther       Date:  2012-04-24       Impact factor: 11.454

7.  Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis.

Authors:  Justin D Crane; Rengasamy Palanivel; Emilio P Mottillo; Adam L Bujak; Huaqing Wang; Rebecca J Ford; Andrew Collins; Regje M Blümer; Morgan D Fullerton; Julian M Yabut; Janice J Kim; Jean-Eric Ghia; Shereen M Hamza; Katherine M Morrison; Jonathan D Schertzer; Jason R B Dyck; Waliul I Khan; Gregory R Steinberg
Journal:  Nat Med       Date:  2014-12-08       Impact factor: 53.440

8.  Inhibition of allergic inflammation by supplementation with 5-hydroxytryptophan.

Authors:  Hiam Abdala-Valencia; Sergejs Berdnikovs; Christine A McCary; Daniela Urick; Riti Mahadevia; Michelle E Marchese; Kelsey Swartz; Lakiea Wright; Gökhan M Mutlu; Joan M Cook-Mills
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-27       Impact factor: 5.464

Review 9.  Pulmonary hypertension: therapeutic targets within the serotonin system.

Authors:  Y Dempsie; M R MacLean
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

10.  Strain-specific genetics, anatomy and function of enteric neural serotonergic pathways in inbred mice.

Authors:  Kathleen B Neal; Laura J Parry; Joel C Bornstein
Journal:  J Physiol       Date:  2008-12-08       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.